Related Experiment Video
Updated: Sep 20, 2025

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Individual reference intervals for personalised interpretation of clinical and metabolomics measurements
Murih Pusparum1, Gökhan Ertaylan2, Olivier Thas3
1Data Science Institute, I-Biostat, Hasselt University, Hasselt 3500, Belgium; Health, Flemish Institute for Technological Research (VITO), Mol 2400, Belgium.
Abstract:
The Population Reference Interval (PRI) refers to the range of outcomes that are expected in a healthy population for a clinical or a diagnostic measurement. It is widely used in daily clinical practice and is essential for assisting clinical decision-making in diagnostics and treatment. In this manuscript, we start from the observation that each healthy individual has its own range for a given variable, depending on personal biological traits. This Individual Reference Interval (IRI) can be calculated and be utilised in clinical practice, in combination with the PRI for improved decision making. Nonparametric estimation of IRIs would require quite long time series. To circumvent this problem, we propose methods based on quantile models in combination with penalised parameter estimation methods that allow for information-sharing among the subjects. Our approach considers the calculation of an IRI as a prediction problem rather than an estimation problem. We perform a simulation study designed to benchmark the methods under different assumptions. From the simulation study we conclude that the new methods are robust and provide empirical coverages close to the nominal level. Finally, we evaluate the methods on real-life data consisting of eleven clinical tests and metabolomics measurements from the VITO IAM Frontier study.
Related Concept Videos
Drug Concentrations: Measurements
Plasma...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

